We are live on ! Find out more
SANA icon

Sana Biotechnology
SANA

136 hedge funds and large institutions have $493M invested in Sana Biotechnology in 2023 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 10

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

24% more call options, than puts

Call options by funds: $204K | Put options by funds: $165K

11% more funds holding

Funds holding: 123 → 136 (+13)

8% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 39

5.72% less ownership

Funds ownership: 70.47% → 64.75% (-5.7%)

39% less capital invested

Capital invested by funds: $804M → $493M (-$311M)

Holders
136
Holders Change
+13
Holders Change %
+10.57%
% of All Funds
2.16%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
23
Increased
42
Reduced
39
Closed
10
Calls
$204K
Puts
$165K
Net Calls
+$39K
Net Calls Change
-$8.07M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$10.2M
2
PHS
PFM Health Sciences
California
+$6.61M
3
SCM
Suvretta Capital Management
New York
+$4.57M
4
SOMRS
State of Michigan Retirement System
Michigan
+$3.7M
5
GCP
GSA Capital Partners
United Kingdom
+$2.9M

Top Sellers

Rank Fund Capital Flow
1
FP
Flagship Pioneering
Massachusetts
-$44.5M
2
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
-$20.1M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.01M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$3.4M
5
AG
Artal Group
Luxembourg
-$2.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$2.29M +$16.9K +3,140 +0.5%
GCP
27
GSA Capital Partners
United Kingdom
$2.09M +$2.9M +540,250 New
Millennium Management
28
Millennium Management
New York
$1.99M -$427K -79,372 -13%
Verition Fund Management
29
Verition Fund Management
Connecticut
$1.95M +$776K +144,332 +40%
Deutsche Bank
30
Deutsche Bank
Germany
$1.85M +$45.2K +8,408 +2%
ACH
31
ArrowMark Colorado Holdings
Colorado
$1.81M +$2.52M +468,749 New
Capital International Investors
32
Capital International Investors
California
$1.67M -$965K -179,600 -29%
Bank of America
33
Bank of America
North Carolina
$1.56M +$124K +23,153 +6%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$1.43M +$3.99K +742 +0.2%
TD Asset Management
35
TD Asset Management
Ontario, Canada
$1.4M +$975K +181,326 +100%
WP
36
Woodline Partners
California
$1.37M +$17.9K +3,328 +1%
Rafferty Asset Management
37
Rafferty Asset Management
New York
$1.26M -$58.6K -10,901 -3%
Skandinaviska Enskilda Banken (SEB)
38
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.22M +$1.69M +313,900 New
Citadel Advisors
39
Citadel Advisors
Florida
$1.1M +$892K +166,040 +139%
Corient Private Wealth
40
Corient Private Wealth
Florida
$1.09M +$508K +94,500 +50%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$978K -$190K -35,385 -12%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$972K +$95.1K +17,687 +8%
Norges Bank
43
Norges Bank
Norway
$966K – – –
Mitsubishi UFJ Trust & Banking
44
Mitsubishi UFJ Trust & Banking
Japan
$901K -$85.5K -15,900 -6%
HMC
45
Harvard Management Company
Massachusetts
$837K -$1.36M -252,373 -54%
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$833K +$61.3K +11,399 +6%
Barclays
47
Barclays
United Kingdom
$796K +$32.8K +6,096 +3%
Renaissance Technologies
48
Renaissance Technologies
New York
$754K +$1.05M +194,869 New
Jacobs Levy Equity Management
49
Jacobs Levy Equity Management
New Jersey
$731K +$564K +105,017 +125%
Swiss National Bank
50
Swiss National Bank
Switzerland
$726K – – –
1
2
3 4 5

SANA Hedge Fund Activity: Q3 2023 in Review

136 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Sana Biotechnology (SANA) for Q3 2023, worth a combined $493M — down 39% from $804M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new SANA positions and 10 closed out — a net gain of 13 holders — while 42 added to existing stakes and 39 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $10.2M. The largest seller was Flagship Pioneering, cutting an estimated $44.5M.

  • 136 institutional investors held Sana Biotechnology (SANA) as of Q3 2023, up from 123 in Q2 2023.
  • Funds reported $493M of Sana Biotechnology stock for Q3 2023, down 39% quarter-over-quarter.
  • 23 funds opened new Sana Biotechnology positions in Q3 2023 and 10 closed out, a net change of +13 holders.
  • The largest Sana Biotechnology buyer in Q3 2023 was T. Rowe Price Associates, an estimated $10.2M added.
  • The largest Sana Biotechnology seller in Q3 2023 was Flagship Pioneering, an estimated $44.5M sold.

Based on aggregated 13F filings for Q3 2023.